Moody's Downgraded Rating On Roche Following Genentech Buyout
Tweet Send to a Friend
Moody's downgraded the long-term rating of Roche Holding AG to A2 from Aa1 following the company's successful tender offer ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE